Literature DB >> 20564224

Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon.

Qing Zhong1, Renu A Kowluru.   

Abstract

Hyperglycemia is considered as one of the major determinants in the development of diabetic retinopathy, but the progression of retinopathy resists arrest after hyperglycemia is terminated, suggesting a metabolic memory phenomenon. Diabetes alters the expression of retinal genes, and this continues even after good glycemic control is re-instituted. Since the expression of genes is affected by chromatin structure that is modulated by post-translational modifications of histones, our objective is to investigate the role of histone acetylation in the development of diabetic retinopathy, and in the metabolic memory phenomenon. Streptozotocin-induced rats were maintained either in poor glycemic control (PC, glycated hemoglobin, GHb >11%) or good glycemic control (GC, GHb <6%) for 12 months, or allowed to be in PC for 6 months followed by in GC for 6 months (PC-GC). On a cellular level, retinal endothelial cells, the target of histopathology of diabetic retinopathy, were incubated in 5 or 20 mM glucose for 4 days. Activities of histone deacetylase (HDAC) and histone acetyltransferase (HAT), and histone acetylation were quantified. Hyperglycemia activated HDAC and increased HDAC1, 2, and 8 gene expressions in the retina and its capillary cells. The activity HAT was compromised and the acetylation of histone H3 was decreased. Termination of hyperglycemia failed to provide any benefits to diabetes-induced changes in retinal HDAC and HAT, and histone H3 remained subnormal. This suggests "in principle" the role of global acetylation of retinal histone H3 in the development of diabetic retinopathy and in the metabolic memory phenomenon associated with its continued progression. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20564224      PMCID: PMC2907436          DOI: 10.1002/jcb.22644

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  46 in total

1.  Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.

Authors:  Renu A Kowluru; Mamta Kanwar
Journal:  Free Radic Biol Med       Date:  2009-04-05       Impact factor: 7.376

Review 2.  Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.

Authors:  Patrizia Casaccia-Bonnefil; Giovanna Pandozy; Fabrizio Mastronardi
Journal:  Prog Neurobiol       Date:  2008-09-26       Impact factor: 11.685

Review 3.  Epigenetic control.

Authors:  Geneviève P Delcuve; Mojgan Rastegar; James R Davie
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

Review 4.  Targeting tumor angiogenesis with histone deacetylase inhibitors.

Authors:  Leigh Ellis; Hans Hammers; Roberto Pili
Journal:  Cancer Lett       Date:  2008-12-25       Impact factor: 8.679

Review 5.  Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.

Authors:  Sally A Madsen-Bouterse; Renu A Kowluru
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

Review 6.  The many roles of histone deacetylases in development and physiology: implications for disease and therapy.

Authors:  Michael Haberland; Rusty L Montgomery; Eric N Olson
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

7.  Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.

Authors:  Neil H White; Wanjie Sun; Patricia A Cleary; Ronald P Danis; Matthew D Davis; Dean P Hainsworth; Larry D Hubbard; John M Lachin; David M Nathan
Journal:  Arch Ophthalmol       Date:  2008-12

8.  High glucose-induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells.

Authors:  An-Fei Li; Sayon Roy
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-21       Impact factor: 4.799

9.  Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia.

Authors:  Assam El-Osta; Daniella Brasacchio; Dachun Yao; Alessandro Pocai; Peter L Jones; Robert G Roeder; Mark E Cooper; Michael Brownlee
Journal:  J Exp Med       Date:  2008-09-22       Impact factor: 14.307

10.  Role of glyceraldehyde 3-phosphate dehydrogenase in the development and progression of diabetic retinopathy.

Authors:  Mamta Kanwar; Renu A Kowluru
Journal:  Diabetes       Date:  2008-10-13       Impact factor: 9.461

View more
  61 in total

1.  Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC).

Authors:  Chandra Sekhar Rao Kadiyala; Ling Zheng; Yunpeng Du; Elizabeth Yohannes; Hung-Ying Kao; Masaru Miyagi; Timothy S Kern
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

2.  Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?

Authors:  Renu A Kowluru; Qing Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

3.  Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.

Authors:  Ahmet Ozer; Cengiz Z Altuntas; Fuat Bicer; Kenan Izgi; Scott J Hultgren; Guiming Liu; Firouz Daneshgari
Journal:  Pathog Dis       Date:  2015-02-05       Impact factor: 3.166

4.  Acetylation: a lysine modification with neuroprotective effects in ischemic retinal degeneration.

Authors:  Oday Alsarraf; Jie Fan; Mohammad Dahrouj; C James Chou; Donald R Menick; Craig E Crosson
Journal:  Exp Eye Res       Date:  2014-07-23       Impact factor: 3.467

5.  Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.

Authors:  Zhuo Chen; Feng Miao; Andrew D Paterson; John M Lachin; Lingxiao Zhang; Dustin E Schones; Xiwei Wu; Jinhui Wang; Joshua D Tompkins; Saul Genuth; Barbara H Braffett; Arthur D Riggs; Rama Natarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 6.  Epigenetic mechanisms in diabetic vascular complications.

Authors:  Marpadga A Reddy; Rama Natarajan
Journal:  Cardiovasc Res       Date:  2011-01-25       Impact factor: 10.787

7.  Diabetic retinopathy and transcriptional regulation of a small molecular weight G-Protein, Rac1.

Authors:  Renu A Kowluru; Manish Mishra; Binit Kumar
Journal:  Exp Eye Res       Date:  2016-04-22       Impact factor: 3.467

8.  Impaired transport of mitochondrial transcription factor A (TFAM) and the metabolic memory phenomenon associated with the progression of diabetic retinopathy.

Authors:  Julia M Santos; Renu A Kowluru
Journal:  Diabetes Metab Res Rev       Date:  2013-03       Impact factor: 4.876

9.  Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation.

Authors:  Qing Zhong; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-14       Impact factor: 4.799

Review 10.  Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

Authors:  Wei Li; Keith A Webster; Michelle E LeBlanc; Hong Tian
Journal:  Cell Mol Life Sci       Date:  2017-08-30       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.